Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NT-4 ELISA Kit (AC3743)
Cat.#: ASET-2332
Specifications
Description Human NT-4 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human NT-4 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 25.13 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 400-6400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1983 Mouse SRD5A1 ELISA Kit (AC3394) Quantitative inquiry ASET-1354 Human Carboxypeptidase E ELISA Kit (AC2765) Quantitative inquiry ASET-1731 Human CD45 ELISA Kit (AC3142) Quantitative inquiry ASET-1401 Rat Estrogen Receptor beta ELISA Kit (AC2812) Quantitative inquiry ASET-1851 Human APC ELISA Kit (AC3262) Quantitative inquiry ASET-1259 Rat GJB2 ELISA Kit (AC2670) Quantitative inquiry ASET-1776 Human Synapsin I ELISA Kit (AC3187) Quantitative inquiry ASET-2402 Horse IL-6 ELISA Kit (AC3813) Quantitative inquiry ASET-1060 Mouse Homer1 ELISA Kit (AC2471) Quantitative inquiry ASET-2144 Rabbit Leptin ELISA Kit (AC3555) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket